Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.

BACKGROUND: Budesonide/formoterol maintenance and reliever therapy maintains asthma control and reduces exacerbation frequency compared with higher fixed-dose combination regimens. Its effects on eosinophilic airway inflammation and structure are unknown. OBJECTIVE: We sought to compare the effects...

Descripció completa

Dades bibliogràfiques
Autors principals:	Pavord, I, Jeffery, P, Qiu, Y, Zhu, J, Parker, D, Carlsheimer, A, Naya, I, Barnes, N
Format:	Journal article
Idioma:	English
Publicat:	2009

Ítems similars

Controlled trial of budesonide–formoterol as needed for mild asthma
per: Beasley, R, et al.
Publicat: (2019)

Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
per: Barnes, N, et al.
Publicat: (2007)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
per: V. A. Nikitin, et al.
Publicat: (2016-03-01)

Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
per: Sergey K. Zyryanov, et al.
Publicat: (2022-08-01)

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
per: O'Connor Brian J, et al.
Publicat: (2011-12-01)

Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms
per: Ryosuke Souma, et al.
Publicat: (2018-05-01)

Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
per: Lombardi DM, et al.
Publicat: (2006-01-01)

Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
per: J Mark FitzGerlad, et al.
Publicat: (2003-01-01)

An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing
per: L Meyer, et al.
Publicat: (2003-05-01)

Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose
per: Masayuki Hojo, et al.
Publicat: (2013-01-01)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
per: Gabriele Nicolini, et al.
Publicat: (2008-11-01)

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
per: O.I. Simonova
Publicat: (2010-05-01)

NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE
per: O.I. Simonova
Publicat: (2010-01-01)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
per: Peter N Huynh, et al.
Publicat: (2010-02-01)

Is It Really Feasible to Use Budesonide–Formoterol as Needed for Mild Persistent Asthma? A Systematic Review and Meta-Analysis
per: Xiang Tong, et al.
Publicat: (2021-06-01)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
per: Arun Jenish J, et al.
Publicat: (2012-03-01)

The Study of Efficacy, Tolerability and Safety of Theophylline Given Along with Formoterol Plus Budesonide in COPD
per: Subramanian, et al.
Publicat: (2015-02-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
per: Brightling, C, et al.
Publicat: (2000)

Asthma control, airway responsiveness and airway inflammation.
per: Pavord, I
Publicat: (2009)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
per: Hyun-moon Back, et al.
Publicat: (2020-04-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
per: Taisuke Akamatsu, et al.
Publicat: (2012-01-01)

Efficacy of Budesonide in Combination with Formoterol in Patients with Inadequately Controlled Asthma on Fluticasone in Combination with Salmeterol
per: Yoshihiro Kanemitsu, et al.
Publicat: (2012-01-01)

A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
per: Narongwit Nakwan, et al.
Publicat: (2022-07-01)

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
per: David B. Price, et al.
Publicat: (2018-06-01)

Some aspects of application of the combination of formoterol and budesonide: what is changed?
per: A. A. Vizel, et al.
Publicat: (2019-12-01)

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
per: Pavord, I, et al.
Publicat: (2007)

Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
per: Elizabeth Miller, et al.
Publicat: (2007-01-01)

Review: Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma
per: Bertil Lindmark
Publicat: (2008-10-01)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
per: Mohsen Sadatsafavi, et al.
Publicat: (2021-10-01)

Budesonide/formoterol combination in COPD: a US perspective
per: Amir Sharafkhaneh, et al.
Publicat: (2010-10-01)

Inhalation of Budesonide/Formoterol Increases Diaphragm Muscle Contractility
per: Chiyohiko Shindoh, et al.
Publicat: (2012-01-01)

Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
per: A. V. Еmelyanov
Publicat: (2013-12-01)

High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
per: Massimo Corradi, et al.
Publicat: (2016-10-01)

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
per: Andersson Eva, et al.
Publicat: (2009-02-01)

Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study
per: Shambo Samrat Samajdar, et al.
Publicat: (2023-01-01)

Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases.
per: María del Carmen Cano-Salas, et al.
Publicat: (2024-12-01)

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
per: Fang Yi, et al.
Publicat: (2022-10-01)

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
per: Östlund Ollie, et al.
Publicat: (2011-04-01)

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
per: Woodcock Ashley, et al.
Publicat: (2007-09-01)

Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
per: Konstantinos P. Exarchos, et al.
Publicat: (2022-06-01)